Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Microbot Medical announced that the U.S. FDA has granted 510(k) clearance for its LIBERTY® System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular ...

BRAINTREE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Microbot Medical (MBOT) ® Inc. (Nasdaq: MBOT), developer of the innovative single use LIBERTY ® Endovascular Robotic System, announces that its ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands ...

Shares of NASDAQ MBOT opened at $1.70 on Monday. Microbot Medical has a 1 year low of $0.82 and a 1 year high of $3.38. The company has a market capitalization of $59.06 million, a PE ratio of -2.12 ...

HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced its participation in the inaugural ...

MICROBOT MEDICAL ($MBOT) is expected to release its quarterly earnings data on Tuesday, March 25th after market close, per Finnhub. Analysts are expecting revenue of ...